Literature DB >> 1295705

Microalbuminuria in non-insulin-dependent diabetes.

C E Mogensen1, E M Damsgaard, A Frøland, S Nielsen, N de Fine Olivarius, A Schmitz.   

Abstract

According to international consensus, microalbuminuria is defined as an elevated urinary albumin excretion rate (UAER) of 20-200 micrograms/min, which is below the proteinuric range. Nephropathy is a major complication in IDDM, seen in about 30% of patients after many years of diabetes. Increasing microalbuminuria is an excellent marker of subsequent nephropathy in these patients. End-stage diabetic nephropathy is also important in NIDDM, but in most Western countries this serious complication eventually develops in only 5 to 10% of cases, whereas the majority of patients die before this from cardiovascular disease. In completely healthy individuals there is no clear correlation between age and UAER, at least up to about 70 years of age. The mean excretion rate is around 5 micrograms/min, with a considerable range, but excretion only rarely exceeds 15 micrograms/min. In population studies among middle-aged and elderly individuals, higher values are seen. In newly diagnosed NIDDM about 40% of patients show an excretion rate above 15-20 micrograms/min. There is a significant but not precise correlation between albumin excretion rate and glycemic control, and usually UAER is reduced by standard antidiabetic treatment. In a considerable number of patients, high values cannot be reduced. In the course of NIDDM about 20-30% of patients show microalbuminuria. In patients with known diabetes, microalbuminuria is related not only to subsequent diabetic proteinuria, but even more strongly to early death, mainly from cardiovascular disease. Even slight microalbuminuria (15-40 mg/l in early morning urines) is clearly associated with increased mortality. In subjects with newly detected elevated blood glucose (by screening) microalbuminuria also predicts early mortality. The mechanisms are not established, but several arteriosclerosis-related risk factors are seen more frequently in patients with microalbuminuria, e.g. lipid abnormalities, elevated systolic blood pressure (BP), hemostatic measures, as well other markers of cardiovascular disease. Usually there is a significant but not precise correlation between BP and UAER in groups of patients throughout the course of diabetes. New studies document that also in the elderly background population microalbuminuria is a significant risk factor for early death, maybe even stronger than the established risk markers, which thus may be confounded with the presence of microalbuminuria.

Entities:  

Mesh:

Year:  1992        PMID: 1295705

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  9 in total

1.  Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women.

Authors:  A Juutilainen; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  Diabetologia       Date:  2005-12-20       Impact factor: 10.122

2.  Impaired glucose tolerance and its co-variates among 2079 non-diabetic elderly subjects. Ten-year mortality and morbidity in the CASTEL study. CArdiovascular STudy in the ELderly.

Authors:  E Casiglia; P Pauletto; A Mazza; G Ginocchio; G di Menza; L Pavan; P Tramontin; M Capuani; A C Pessina
Journal:  Acta Diabetol       Date:  1996-12       Impact factor: 4.280

3.  Evaluation of the URiSCAN 2 ACR Strip to estimate the urine albumin/creatinine ratios.

Authors:  Sangeun Lim; Hui-Jin Yu; Seungjun Lee; Hyosoon Park; Min-Jung Kwon; Hee-Yeon Woo
Journal:  J Clin Lab Anal       Date:  2017-06-26       Impact factor: 2.352

4.  Evaluation of the URiSCAN super cassette ACR semiquantitative urine dipstick for microalbuminuria screening.

Authors:  Min-Chul Cho; Misuk Ji; So Young Kim; Wonho Choe; Woochang Lee; Sail Chun; Won-Ki Min
Journal:  J Clin Lab Anal       Date:  2014-02-27       Impact factor: 2.352

5.  Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM.

Authors:  A Schmitz; M Vaeth; C E Mogensen
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

6.  Urinary albumin excretion rate and 24-h ambulatory blood pressure in NIDDM with microalbuminuria: effects of a monounsaturated-enriched diet.

Authors:  S Nielsen; K Hermansen; O W Rasmussen; C Thomsen; C E Mogensen
Journal:  Diabetologia       Date:  1995-09       Impact factor: 10.122

7.  Carotid stiffness and microalbuminuria in patients with type 2 diabetes.

Authors:  Wei-Wei Zhan; Yu-Hong Chen; Yi-Fei Zhang; Ying Zhu; Yan-Yan Lin; Xin-Ping Ren; Xiao-Ying Li; Yan-Ping Liu
Journal:  Endocrine       Date:  2009-04-15       Impact factor: 3.633

8.  Correlation between the ankle-brachial index and microalbuminuria with certain risk factors in type 2 diabetes patients.

Authors:  Van Tuan Nguyen; Ha Linh Phan; Thi Minh Hoang; Thi Phuong Lan Dam; Thi Hang Ho; Quang Thuan Huynh
Journal:  Cardiovasc Endocrinol Metab       Date:  2021-06-09

9.  Assessment of carotid atherosclerosis in type 2 diabetes mellitus patients with microalbuminuria by high-frequency ultrasonography.

Authors:  Yu-Hong Zhang; Yuan Gao; Xin Mao; Jing Shang; Ben-Li Su
Journal:  Int J Endocrinol       Date:  2013-03-14       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.